Zimmer Biomet Holdings, Inc. (ZBH)
| Previous close | 163.69 |
| Open | 162.95 |
| Bid | 0.00 x 1000 |
| Ask | 164.48 x 800 |
| Day's range | 162.21 - 165.37 |
| 52-week range | 74.37 - 170.05 |
| Volume | 1,415,563 |
| Avg. volume | 1,132,795 |
| Market cap | 34.192B |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.67 |
| Earnings date | 10 May 2021 - 14 May 2021 |
| Forward dividend & yield | 0.96 (0.58%) |
| Ex-dividend date | 24 Dec 2020 |
| 1y target est | 178.81 |
- PR Newswire
Zimmer Biomet Announces Changes to Company's Board of Directors
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced changes to the Company's Board of Directors, including:
- PR Newswire
Zimmer Biomet to Present at the Cowen 41st Annual Health Care Conference
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that President and CEO Bryan Hanson and Executive Vice President and CFO Suky Upadhyay will be presenting at the Cowen 41st Annual Health Care Conference on Thursday, March 4, 2021, at 11:10 a.m. Eastern Time.
- PR Newswire
Vafa Jamali Appointed as CEO of "NewCo", New Publicly Traded Spine and Dental Company to Spin Out of Zimmer Biomet
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that after an extensive search, Vafa Jamali has been appointed as CEO of "NewCo", the independent, publicly traded company that will be created by a previously announced spin off transaction, expected to close in mid-2022. NewCo will be comprised of Zimmer Biomet's current Spine and Dental businesses.
